Wednesday, July 20, 2022

Bioimpedance Analyzer Market - Industry Size, Share, Growth & Forecast 2027 | UnivDatos

 


Bioimpedance analysis is a non-invasive, mainly used approach for body composition measurements and assessment of clinical conditions. It is a technique where the resistance offered by the body against the flow of current is. Furthermore, the analysis is predominantly used to measure the amount of body fat. Increasing health consciousness in modern society and changing perception of the people about the traditional methods of fat measurement such as weight measurement that were not much accurate, act as the driving factors for the market growth of the bioimpedance analyzers. Additionally, the governments are also realizing the importance of a healthy lifestyle for better health and influencing the citizens to take care of their health, also being the contributing factor to increasing the market size of the equipment. Soaring lifestyle diseases such as obesity, and diabetes coupled with technological advancements become the major driving factors for the market growth of the bioimpedance analyzer.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22594

According to ‘UnivDatos Market Insights (UMI)’ research reportBioimpedance Analyzer Market Analysis, 2020”, the Bioimpedance Analyzer market is projected to grow at a CAGR of ~9% during 2021-27F. The increasing lifestyle-associated diseases have attracted government attention which led to an increase in the investment in the health care sector and fitness sector contributing to the market growth of the bioimpedance analyzer. According to CDC, obese people are 36% more vulnerable to a heart attack than people with other disorders. 

The ongoing COVID-19 pandemic across the world has had a tremendous impact on different spectra of society, the market for bioimpedance analyzers no less. The market for bioimpedance analyzers faced an impact due to movement restrictions, which have forced people to stay home, and, thus, there has been a huge decline in the hospital and clinic visits and fitness clubs. This has affected the trade of Bioimpedance Analyzer due to the reduced demand and widespread financial distress.  

Based on Application, the market is bifurcated into whole-body measurement and segmental body measurement. In 2020, segmental body measurement is expected to have a significant share in the market during the forecast period attributed to the growing number of obesity cases and related diseases. Moreover, it analyses each segment of the body and provides more accurate data.

Download Free Sample of this Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=22594

On the basis of Product Type, the market is bifurcated into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. Amongst them, the market for the multi-frequency analyzer is expected to widen, the multiple frequencies enable the device to determine the constitution of different elements.  

Based on End-User, the market is segmented into hospitals, fitness clubs & wellness centers, home users, and others. Among them, fitness clubs and wellness centers account for the major market share. Furthermore, a continuous increase in the number of fitness clubs and wellness centers coupled with the rapid urbanization and celebrity endorsements encourages people to focus more on personal health resulting in creating better opportunities for the fitness clubs and centers in the market in the forecast period.

For more informative information, please visit us – https://univdatos.com/report/bioimpedance-analyzer-market/

APAC to witness Significant Growth

For a better understanding of the market adoption of Bioimpedance Analyzer End- User, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, and Rest of APAC), and Rest of World. During the forecast period, APAC is expected to have a higher CAGR due to modernization and changing lifestyles causing different diseases, which have fueled manufacturing output levels, and positively influencing the global bioimpedance analyzer market. Developing countries such as China and India undergoing rapid industrialization and urbanization and are dealing with surging lifestyle disorders. Moreover, the APAC region also consists of the major companies of bioimpedance analyzers coupled with the growing population of the region making it the ideal location for market growth. 

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the Bioimpedance Analyzer Market are OMRON Corporation, Tanita Corporation, InBody Pvt. Ltd, RJL Systems Inc., seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare Inc., Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., and Bodystat Ltd. The players are focused on launching new solutions and services, partnerships, and collaborations with major companies expanding their geographical reach to get a competitive edge in the industry.

 “Bioimpedance Analyzer Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for bioimpedance analyzer providers across the Globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitors’ capabilities on 16 parameters. This will help companies in the formulation of go to Market Strategies and identifying the blue ocean for its offerings.

For more informative information, please visit us – https://univdatos.com/report/bioimpedance-analyzer-market/

Market Segmentation:

1.     By Application (Whole-body measurement and Segmental body measurement)

2.     By Product type (Multi-Frequency Bioimpedance Analyzers, Single-Frequency Bioimpedance Analyzers, And Dual-Frequency Bioimpedance Analyzers)

3.     By End User (Hospitals, Fitness Clubs & Wellness Centers, Home Users, and Others.)

4.     By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.     By Company (OMRON Corporation, Tanita Corporation, InBody Pvt. Ltd, RJL Systems Inc., seca GmbH & Co. KG, EVOLT 360, SELVAS Healthcare Inc., Charder Electronic Co. Ltd., Fook Tin Group Holding Ltd., and Bodystat Ltd.)

Key questions answered in the study:

1.     What are the current and future trends of the bioimpedance analyzer industry?

2.     How the industry has been evolving in terms of product type and industry areas?

3.     How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.     What are the key growth drivers and challenges for the bioimpedance analyzer industry?

5.     What are the customer orientation, purchase behavior, and expectations from the bioimpedance analyzer firms across various regions?  

Table of Content –

1 MARKET INTRODUCTION

2 RESEARCH METHODOLOGY OR ASSUMPTION

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BIOIMPEDANCE ANALYZER MARKET

6 BIOIMPEDANCE ANALYZER MARKET REVENUE (USD BN), 2019-2027F

7 MARKET INSIGHTS BY APPLICATION

8 MARKET INSIGHTS BY PRODUCT TYPE

9 MARKET INSIGHTS BY END-USER

10 MARKET INSIGHTS BY REGION

11 BIOIMPEDANCE ANALYZER MARKET DYNAMICS

12 BIOIMPEDANCE ANALYZER MARKET OPPORTUNITIES

13 BIOIMPEDANCE ANALYZER MARKET TRENDS

14 POLICY AND REGULATORY LANDSCAPE

15 DEMAND AND SUPPLY-SIDE ANALYSIS

16 COMPETITIVE SCENARIO

17 COMPANY PROFILED

18 DISCLAIMER

Browse Other Related Research Reports from UnivDatos Market Insights

·       Continuous Positive Airway Pressure (CPAP) Device Market to Reach US$ 4 Billion by 2026, Globally |CAGR: 9% |

·       Artificial Intelligence (AI) in Healthcare Market to Reach US$ 26.5 Billion by 2025, Globally |CAGR: 41%|

·       In-Vitro Diagnostics (IVDs) Market to reach US$ 98 Billion by 2025, Globally |CAGR: 5.24%|

·       Critical Care Equipment Market to Reach US$ 38 Billion by 2026 Globally |CAGR: 6%|

Labels:

0 Comments:

Post a Comment

Subscribe to Post Comments [Atom]

<< Home